News Search Results
Jun 09, 2026, 08:34 ET Immorta Bio Discusses its AI-Enabled Personalized Therapeutic Paradigm for Restoring Youthful Biology at Leading Global Biotech Forum
Lifespan: AI, Aging & the Future of Longevity Innovation," at MedTech World North America. The panel brought together recognized leaders in biotechnology, longevity science, artificial intelligence, regenerative medicine, and healthcare innovation. The discussion focused on how artificial intelligence
More news about: Immorta Bio Inc.
Jun 09, 2026, 08:30 ET AllerGene AI Therapeutics Appoints Biotech Industry Veteran Gad Berdugo to Board of Directors
initiatives.MIAMI, June 9, 2026 /PRNewswire/ -- AllerGene AI Therapeutics, a biotechnology company developing first-in-class in vivo targeted-lipid nanoparticle (tLNP) mRNA chimeric antigen receptor (CAR) therapies designed to prevent
More news about: AllerGene AI Therapeutics
Jun 09, 2026, 08:30 ET Alexandria Real Estate Equities, Inc. Continues its Generational Consequential Leadership as Pioneer of The Commercial Life Science Ecosystem and Second Most Active Early-Stage Life Science Investor in its New York City Life Science Cluster
critical value-creation event for the region's innovation economy.Intra-Cellular Therapies (ITCI) represents one of the most compelling biotechnology success stories. More than 24 years ago, Alexandria Venture Investments made its first investment in Intra-Cellular Therapies' Series A financing,
More news about: Alexandria Real Estate Equities, Inc.
Jun 09, 2026, 08:23 ET First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody
www.harbourbiomed.com.About Windward BioWindward Bio is a clinical-stage biotechnology company with deep discovery, development, and commercialization expertise committed to transforming the treatment of people living with serious
More news about: Harbour BioMed
Jun 09, 2026, 08:22 ET Rocket One To File Patent Applications for AI-Powered Autonomous Defense and Space Security Platform Designed to Protect the Infrastructure of the Future
Company is also positioned to pursue opportunities in nano-launch systems and nanosatellite deployment. The Company's biotechnology pipeline, including, but not limited to, HT-001, HT-KIT, HT-ALZ, and its GDNF-based metabolic program, will continue to
More news about: Rocket One Inc.
Jun 09, 2026, 08:14 ET Kelun-Biotech Partner Windward Bio Announces First Patients Dosed in Phase 2 SIRIUS COPD Study of SKB378/WIN378
https://en.kelun-biotech.com/. About Windward Bio Windward Bio is a clinical-stage biotechnology company with deep discovery, development, and commercialization expertise committed to transforming the treatment of people living with serious
More news about: Kelun-Biotech
Jun 09, 2026, 08:08 ET Selagine Plasma to Advance Pooled Plasma Eye Drops for Moderate-to-Severe Dry Eye
https://eyewiki.org/Autologous_and_Allogenic_Serum_TearsAbout Selagine, Inc.Selagine, Inc. is a clinical-stage biotechnology company spun out from the University of Illinois Chicago and dedicated to developing novel therapies for ocular surface diseases. Selagine's programs
More news about: Selagine, Inc.
Jun 09, 2026, 08:02 ET Kyowa Hakko USA's Cognizin® Citicoline Featured in Wellex's New Creatine Well
available on Amazon and Fullscript.About Kyowa Hakko USAKyowa Hakko USA is a subsidiary of Kyowa Hakko Bio Co., Ltd., a global biotechnology company with over 75 years of expertise in fermentation, purification, and modification of bioactive substances. Kyowa Hakko Bio is dedicated to
More news about: Kyowa Hakko U.S.A
Jun 09, 2026, 08:00 ET Matica Biotechnology announces engagement by University Health Network (UHN) to supply cGMP Manufacturing of IL-10 Adenoviral Therapy for Lung Transplantation
end-to-end development and manufacturing services from early process development through cGMP production.About Matica Biotechnology, Inc.Matica Biotechnology is a viral vector Contract Development and Manufacturing Organization (CDMO) that leverages advanced technologies at its purpose-built
More news about: Matica Biotechnology, Inc.
Jun 09, 2026, 03:20 ET [68Ga]Ga-PentixaFor in Primary Aldosteronism: Billion-Dollar Potential in an Underserved Mass Market
CXCR4 expression in vivo.About Pentixapharm Pentixapharm Holding AG (Frankfurt Prime Standard: PTP) is a clinically advanced biotechnology company headquartered in Berlin. The company develops precision radiodiagnostics and -therapeutics in oncology and cardiology, anchored in CXCR4-targeted
More news about: Pentixapharm Holding AG
Jun 08, 2026, 19:00 ET China NMPA Grants IND Clearance to Adcentrx Therapeutics' ADRX-0405 STEAP1 ADC for the Treatment of Late-Stage Solid Tumors, Including Prostate Cancer
Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company advancing Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, today announced that the China
More news about: Adcentrx Therapeutics
Jun 08, 2026, 14:30 ET Lilly's oral GLP-1 Foundayo (orforglipron) delivered superior A1C control and weight loss in three pivotal type 2 diabetes trials
pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Jun 08, 2026, 12:21 ET Rubin Rudman Partner Tyler Franklin Named to the Environmental Business Council of New England's Ocean and Coastal Resources Committee
Rubin Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; hospitality companies; regulated industries, public entities and municipalities; insurance companies
More news about: Rubin Rudman
Jun 08, 2026, 08:31 ET MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential
CAMBRIDGE, Mass., June 8, 2026 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the presentation of new late-breaking data highlighting its obesity and
More news about: MetaVia Inc.
Jun 08, 2026, 08:17 ET Simulations Plus (SLP) Securities Investigation: Johnson Fistel Reviews Revenue Guidance Cut, $77.2M Impairment Charge, and Auditor Dispute
range of $76 million to $80 million. The Company attributed the revised outlook, in part, to market uncertainties affecting pharmaceutical and biotechnology customers, including budget reductions, project cancellations, and delays.Following this announcement, Simulations Plus stock declined more
More news about: Johnson Fistel, PLLP
Jun 08, 2026, 08:00 ET Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London
CAMBRIDGE, Mass., June 8, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (Nasdaq: DCOY), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs™), a new category of antivirals engineered to target shared viral mechanisms conserved across
More news about: Decoy Therapeutics, Inc
Jun 08, 2026, 08:00 ET Argo Biopharma to Present Positive Phase II Updated Results of siRNA Therapeutic BW-20805 for HAE at the EAACI 2026 Congress
HAE attacks with a significant and longer-lasting therapeutic effect.About Argo BiopharmaArgo Biopharma is a clinical-stage biotechnology company committed to developing next-generation RNAi therapeutics to provide better treatment options for patients worldwide. The company has established
More news about: Argo Biopharmaceutical Co., Ltd
Jun 08, 2026, 08:00 ET Vasa Therapeutics to Deliver Two Presentations on VS-041 at ECM2026, Featuring Preclinical and First-in-Human Data and Ongoing Phase 1c Trial Design in HFpEF
Calif., and WROCLAW, Poland, June 8, 2026 /PRNewswire/ -- Vasa Therapeutics ("Vasa"), a clinical stage biotechnology company developing novel therapies for cardiovascular and metabolic aging, announced today that Noreen R. Henig, MD, Chief Medical Officer, will
More news about: Vasa Therapeutics
Jun 08, 2026, 08:00 ET Apnimed Appoints Experienced Pharmaceutical Executive Kevin R. Lind as Chief Executive Officer to Implement Next Phase of Growth Strategy
has over 35 years of experience in the life science Industry. His experience encompasses senior management in large corporate pharmaceutical and biotechnology companies, as well as private equity and venture capital. Mr. Sekhri is currently Chairman, President and CEO of vTv Therapeutics, Inc. From 2019
More news about: Apnimed, Inc.
Jun 08, 2026, 07:30 ET Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Jun 08, 2026, 07:00 ET Dualitas Therapeutics Appoints Karim Dabbagh as Chief Executive Officer to Advance Novel Bispecific Antibody Pipeline Toward the Clinic
Dualitas Therapeutics, Inc., a biotechnology company developing next-generation bispecific antibody therapies for immunology and inflammation ("I&I") indications, has appointed Karim Dabbagh,
More news about: Dualitas Therapeutics
Jun 08, 2026, 07:00 ET Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer
SAN DIEGO, June 8, 2026 /PRNewswire/ -- Protego Biopharma, Inc., a clinical-stage biotechnology company focused on developing small-molecule drugs that target protein misfolding diseases, today announced the appointment of Jae B. Kim, MD, as
More news about: Protego Biopharma
Jun 08, 2026, 05:01 ET Kali Therapeutics Announces Poster Presentation of KT209, a Novel CD19 x CD20 x CD3 Trispecific Antibody, at the EHA 2026 Annual Congress
SAN MATEO, Calif., June 8, 2026 /PRNewswire/ -- Kali Therapeutics, a clinical-stage biotechnology company pioneering next-generation immune-resetting and multi-specific therapies, today announced that preclinical data for KT209, its novel trispecific
More news about: Kali Therapeutics
Jun 08, 2026, 04:09 ET WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards
among Ireland's foremost industry recognition programs, celebrating excellence, innovation, and leadership across the country's pharmaceutical, biotechnology, medical device, and broader life sciences sectors. The company was shortlisted across eight award categories, reflecting the breadth of
More news about: WuXi Biologics
Jun 07, 2026, 21:28 ET Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)
SEOUL, South Korea, June 7, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of positive topline results from its Phase II randomized,
More news about: Dayspring Pharma